Article: Off-Label Drug Use Liability Julia Englebert

Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use. A patient walks into her doctor’s office with a headache. She walks out with a prescription for antidepressants. Doctors commonly prescribe drugs for purposes other than their intended use, but the legal implications of this practice remain unclear. If patients are injured by such […]